Overview
Pharmaceutical

ZERIA PHARMACEUTICAL CO.,LTD.

Zeria Pharmaceutical is a Japanese pharmaceutical company operating across two core segments: prescription pharmaceuticals and consumer healthcare. The prescription drug business encompasses manufacturing and sales of ethical pharmaceuticals in Japan and internationally, notably through its Swiss subsidiary Tillotts Pharma AG, which specializes in gastrointestinal drugs sold across Europe and beyond. The consumer healthcare segment develops and markets OTC pharmaceuticals, health foods, and cosmetics under well-known brands such as Hepalyse, targeting self-medication consumers primarily in Japan and Asia.

Market Cap
¥89.2B
US$569M
EV
¥90.0B
US$574M
Stock¥2,024▲+0.00%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
4.5
x
LTM EV/EBIT
7.0
x
LTM PER
10.8
x
LTM PBR
0.8
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-20.5%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
89.2BUS$569MMarket Cap37.7BUS$241M+ Debt27.7BUS$177M− Cash9.50BUS$60.6M− Inv. Sec.0.23BUS$1.49M+ NCI90.0BUS$574MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
59.5US$380M'22/368.4US$436M'23/375.7US$483M'24/387.3US$557M'25/389.2US$569M'26/3
EBITDA 5Y (¥B)
11.1US$70.6M'22/314.4US$92.1M'23/316.0US$102M'24/319.0US$121M'25/319.0US$121M'26/3
Net Income 5Y (¥B)
3.96US$25.3M'22/36.20US$39.5M'23/37.73US$49.3M'24/39.94US$63.4M'25/38.45US$53.9M'26/3
Capital Structure
74%
26%
EquityD/E 0.35xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
18.7US$119M52.2US$333M'22/323.1US$147M49.4US$315M'23/329.5US$188M46.2US$295M'24/332.5US$207M42.4US$271M'25/337.9US$242M40.4US$257M'26/3
Shareholders
Top 10 hold 43.3%
1
Ibe Co., Ltd.
12.09%
2
The Master Trust Bank of Japan, Ltd. (Trust Account)
7.34%
3
MUFG Bank, Ltd.
4.78%
4
Yukiaki IBE
3.61%
5
MORINAGA MILK INDUSTRY CO.,LTD.
3.34%
6
Sumitomo Mitsui Banking Corporation
3.19%
7
Mizuho Bank, Ltd.
3.19%
8
Sumitomo Mitsui Card Company, Limited
2.04%
9
KISSEI PHARMACEUTICAL CO.,LTD.
1.97%
10
ZERIA PHARMACEUTICAL CO.,LTD. Employee Stock Ownership Association
1.74%
Management
11 officers
Yukiaki IBE
Representative Director, Chairman and CEO
Mar 1972 Director, the Company Apr 1978 Managing Director, the Company Apr 1981 Representative Director, Senior Managing Director, the Company Apr 1982 Representative Director, President, the Company Nov 1994 General Manager, Ethical Pharmaceuticals Sales Division, the Company Mar 1996 In charge of Corporate Planning Department, the Company Jun 2014 Representative Director, Chairman and CEO, the Company (current)
1941-03-17
Mitsuhiro IBE
Representative Director, President and COO
Apr 1994 Joined Fuji Bank, Ltd. Oct 2009 Senior Officer, Corporate Banking Division, Mizuho Bank, Ltd. Apr 2010 General Manager, Accounting Department, the Company Jun 2010 Director, the Company Jun 2010 General Manager, Accounting Department, the Company Apr 2011 In charge of Ethical Pharmaceuticals Sales Division and Consumer Healthcare Sales Division, the Company Jun 2011 Managing Director, the Company Jun 2014 Representative Director, President and COO, the Company (current)
1971-11-17
Tetsuo KOMORI
Director
Jun 1996 Director, Tokai Bank, Ltd. Jun 1998 Managing Executive Officer, Tokai Bank, Ltd. Apr 2001 Senior Managing Executive Officer, Tokai Bank, Ltd. Jun 2002 Representative Director, Deputy President and Executive Officer, UFJ Bank Ltd. Jun 2004 Full-time Adviser, UFJ Card Co., Ltd. Sep 2005 Senior Managing Executive Officer, Nichii Leasing Co., Ltd. Jun 2006 Director, Senior Managing Executive Officer, UFJ Central Lease Co., Ltd. Jun 2006 Substitute Audit & Supervisory Board Member, the Company Apr 2007 Senior Managing Director, Mitsubishi UFJ Lease & Finance Co., Ltd. Jun 2007 Audit & Supervisory Board Member, the Company Jun 2009 Vice President, Director, Mitsubishi UFJ Lease & Finance Co., Ltd. Jun 2010 Representative Director, President, Nichii Leasing Co., Ltd. Jun 2015 Director, Noritake Company, Limited Jun 2015 Director, the Company (current)
1948-01-25
Seiji MORIMOTO
Director
Apr 1975 Joined Ministry of Foreign Affairs of Japan Jan 2002 First Vice Chair, Board, Global Fund to Fight AIDS, Tuberculosis and Malaria Jun 2003 Deputy Permanent Representative, Permanent Mission of Japan to International Organizations in Vienna Apr 2005 Honorary Vice Chair, Board, Global Fund to Fight AIDS, Tuberculosis and Malaria (current) Oct 2005 Deputy Chief of Mission, Embassy of Japan in Germany Jun 2008 Ambassador Extraordinary and Plenipotentiary of Japan to Oman Sep 2011 Executive Director (Dairy and Dairy Products), Agriculture and Livestock Industries Corporation Apr 2013 Visiting Professor, Graduate School of Arts and Sciences, The University of Tokyo (current) Nov 2013 Ambassador Extraordinary and Plenipotentiary of Japan to Sweden Nov 2015 Retired from Ministry of Foreign Affairs of Japan Dec 2015 Senior Adviser, Fujitsu Limited Nov 2018 Member, Advisory Committee, Amano Hiroshi Professor Program, Nagoya University (current) Dec 2018 Senior Adviser, Fujitsu Marketing Limited Jun 2020 Director, the Company (current)
1951-04-02
Yuki OKAZAWA
Director; Managing Executive Officer; General Manager, Administration Division; General Manager, Human Resources Department; in charge of Production & Logistics Division, Legal Department, Secretarial Office and Compliance
Apr 1988 Joined Tokai Bank, Ltd. Oct 2009 Branch Manager, Tsurumi Branch, The Bank of Tokyo-Mitsubishi UFJ, Ltd. May 2014 Branch Manager, Yanagibashi Branch, The Bank of Tokyo-Mitsubishi UFJ, Ltd. May 2016 General Manager, Loan Department (Nagoya), The Bank of Tokyo-Mitsubishi UFJ, Ltd. Oct 2017 General Manager, Accounting Department, the Company Jul 2018 General Manager, General Affairs Department, the Company May 2019 General Manager, Human Resources Department, the Company (current) Nov 2019 General Manager, Administration Division, the Company (current) Jun 2020 Director, the Company Jun 2020 General Manager, Accounting Department, the Company Jun 2020 In charge of Compliance, the Company (current) Jun 2022 Managing Executive Officer, the Company (current) Sep 2022 In charge of Legal Department, the Company (current) Sep 2022 In charge of Secretarial Office, the Company (current) Jun 2023 Director, the Company (current) Apr 2024 In charge of Production & Logistics Division, the Company (current)
1965-01-05
Hirokazu ENDO
Full-time Audit & Supervisory Board Member
Apr 1977 Joined Tokai Bank, Ltd. May 1998 Branch Manager, Shin-Koiwa Branch, Tokai Bank, Ltd. Jan 2002 General Manager, Corporate Business Division No. 4 (Nagoya), UFJ Bank Ltd. Jul 2004 Manager, Loan Management Office, Credit Examination Division No. 5, UFJ Bank Ltd. Jan 2006 General Manager, Accounting Department, the Company Jun 2006 General Manager, Accounting Department, the Company Jun 2007 Director, the Company Feb 2008 General Manager, Administration Division, the Company Jun 2009 Managing Director, the Company Jun 2011 Senior Managing Director, the Company Jun 2014 Deputy President, Director, the Company Jun 2023 Full-time Audit & Supervisory Board Member, the Company (current)
1953-05-03
Hiroyuki KURODA
Full-time Audit & Supervisory Board Member
Sep 2002 Joined the Company Jun 2015 General Manager, Research and Development Planning Department, the Company Feb 2019 Director, Central Research Laboratories, the Company Apr 2024 General Manager, Human Resources Department, the Company Jun 2024 Full-time Audit & Supervisory Board Member, the Company (current)
1966-03-08
Yukiko NAKA
Audit & Supervisory Board Member
Apr 1987 Public Prosecutor Dec 1992 Registered as Attorney-at-law, Daini Tokyo Bar Association Jan 2001 Opened NAKA Law Office (current) Dec 2002 Substitute Audit & Supervisory Board Member, the Company Jun 2003 Audit & Supervisory Board Member, the Company (current)
1960-10-23
Dai KAMISUKI
Audit & Supervisory Board Member
Oct 1992 Joined Chuo Shinko Audit Corporation Apr 1997 Registered as Certified Public Accountant Jul 2001 Opened Kamisuki Certified Public Accountant Office (current) Apr 2005 Registered as Certified Tax Accountant Sep 2012 Joined Meiwa Tax Accounting Corporation Apr 2018 Senior Partner, Meiwa Tax Accounting Corporation (current) Jun 2019 Audit & Supervisory Board Member, the Company (current)
1970-02-05
Kikuo NOMOTO
Director
May 1966 Research Assistant (Bacteriology), School of Medicine, Kyushu University Oct 1973 Associate Professor (Bacteriology), School of Medicine, Kyushu University Jan 1977 Professor, Cancer Research Institute, School of Medicine, Kyushu University Apr 1982 Professor, Institute of Health Sciences, Kyushu University Oct 1995 President, Japan Society for Transplantation Oct 1997 Vice President, Japan Organ Transplant Network (now Japan Organ Transplant Network, public interest incorporated association) Apr 1998 Director, Institute of Health Sciences, Kyushu University Apr 1998 Director, AIDS Prevention Foundation (now AIDS Prevention Foundation, public interest incorporated foundation) Apr 2000 Professor Emeritus, Kyushu University (current) Mar 2001 Chair, Ethics Review Committee, Human Science Promotion Foundation (now Human Science Promotion Foundation, public interest incorporated foundation) Apr 2004 Special Director (Medical Accident Prevention), Japan Council for Quality Health Care, public interest incorporated foundation Apr 2011 President, Japan Organ Transplant Network, public interest incorporated association Apr 2011 Councillor, AIDS Prevention Foundation, public interest incorporated foundation (current) Jun 2017 Director, the Company (current)
1936-06-05
Satomi KOBAYASHI
Director
Apr 2006 Joined Ministry of Agriculture, Forestry and Fisheries of Japan Apr 2008 Secretariat, Food Safety Commission, Cabinet Office Dec 2008 Cabinet Office, Director-General for National Lifestyle Apr 2014 Research Support Staff, Graduate School of Medicine, The University of Tokyo May 2014 Special Researcher, Center for Environmental Health Research, National Institute for Environmental Studies Jun 2015 Project Assistant Professor, Graduate School of Medicine, The University of Tokyo Apr 2019 Representative, HERS M&S Sep 2022 Representative Partner, Health M&S LLC (current) Aug 2025 Director, Japan Occupational Nutrition Association, General Incorporated Association (current) Jun 2026 Director, the Company (current)
1980-09-22
Large Shareholding Reports
No filings
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-06
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-25
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-02-05
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-07
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-05
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-26
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-05
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-01
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-27
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-05
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-06
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-07
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-29
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-06
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-07
Quarterly Securities Report
EDINET
2022-08-08
Quarterly Securities Report
EDINET
2022-06-29
Annual Securities Report
EDINET
2022-02-04
Quarterly Securities Report
EDINET
2021-11-08
Quarterly Securities Report
EDINET
2021-08-10
Quarterly Securities Report
EDINET
2021-06-29
Annual Securities Report
EDINET
2021-02-09
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →